Impact of Fall Risk and Direct Oral Anticoagulant Treatment on Quality-Adjusted Life-Years in Older Adults with Atrial Fibrillation: A Markov Decision Analysis

Keyphrases

• Anticoagulants 20%
• Anticoagulation 40%
• Apixaban 60%
• Aspirin 60%
• Atrial Fibrillation 100%
• Clinical Events 40%
• Direct Oral Anticoagulants 100%
• Fall Risk 100%
• High Risk 20%
• Ischemic Stroke Treatment 20%
• Major Bleed 20%
• Markov Decision Analysis 100%
• Markov Decision Process 20%
• Older Adults 100%
• Older Patients 20%
• Oral Anticoagulant Therapy 100%
• Over 45 20%
• Quality-adjusted Life Years 100%
• Rivaroxaban 60%
• Sensitivity Analysis 40%
• Thrombotic 40%
• Warfarin 40%
• Withholding 20%

Medicine and Dentistry

• Acetylsalicylic Acid 60%
• Anticoagulant 20%
• Anticoagulant Therapy 100%
• Anticoagulation 40%
• Antithrombotic 40%
• Apixaban 60%
• Apoplexy 20%
• Atrial Fibrillation 100%
• Base 20%
• Brain Ischemia 20%
• Ciclonicate 20%
• Clinician 20%
• Decision Making 20%
• Direct Oral Anticoagulant 100%
• Quality Adjusted Life Year 100%
• Rivaroxaban 60%
• Warfarin 40%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylsalicylic Acid 60%
• Anticoagulant Agent 60%
• Apixaban 60%
• Atrial Fibrillation 100%
• Base 20%
• Brain Ischemia 20%
• Cerebrovascular Accident 20%
• Ciclonicate 20%
• Direct Oral Anticoagulant 100%
• Rivaroxaban 60%
• Warfarin 40%